Gen InCode: Bill Rhodes
Jan 08, 2021
Gen InCode, a privately owned UK-based company specializing in cardiovascular disease genetic risk assessment, has appointed Bill Rhodes as non-executive chairman. Rhodes has previously served as worldwide president of Becton Dickinson's Biosciences business and was BD's corporate executive officer for strategy and corporate development. Rhodes also currently serves as chairman at OpGen, Omega Diagnostics Group, and CytoSmart Technologies. He was formerly chairman of the Curetis supervisory board until that company's merger with OpGen.